Goel, Hira LalMercurio, Arthur M.2022-08-232022-08-232013-12-012014-10-08<p>Nat Rev Cancer. 2013 Dec;13(12):871-82. doi: 10.1038/nrc3627. <a href="http://dx.doi.org/10.1038/nrc3627">Link to article on publisher's site</a></p>1474-175X (Linking)10.1038/nrc362724263190https://hdl.handle.net/20.500.14038/26302The function of vascular endothelial growth factor (VEGF) in cancer is not limited to angiogenesis and vascular permeability. VEGF-mediated signalling occurs in tumour cells, and this signalling contributes to key aspects of tumorigenesis, including the function of cancer stem cells and tumour initiation. In addition to VEGF receptor tyrosine kinases, the neuropilins are crucial for mediating the effects of VEGF on tumour cells, primarily because of their ability to regulate the function and the trafficking of growth factor receptors and integrins. This has important implications for our understanding of tumour biology and for the development of more effective therapeutic approaches.en-USAnimalsAntineoplastic AgentsAutocrine CommunicationCapillary PermeabilityHumansMolecular Targeted TherapyNeoplasmsNeoplastic Stem CellsNeuropilinsReceptors, Vascular Endothelial Growth FactorSignal TransductionTumor MicroenvironmentVascular Endothelial Growth Factor ACancer BiologyCellsNeoplasmsVEGF targets the tumour cellJournal Articlehttps://escholarship.umassmed.edu/cancerbiology_pp/2186216672cancerbiology_pp/218